Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00295945 · ClinicalTrials.gov registry record
Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 240
- Enrollment target
NCT00295945 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 240 participants.
The verdict
NCT00295945 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
Study Summary
RATIONALE: Giving pain medication into the space between the wall of the spinal canal and the covering of the spinal cord or giving it into a vein may help lessen pain caused by cancer surgery. It is not yet known whether epidural analgesia is more effective than patient-controlled analgesia in controlling pain in patients who have undergone surgery for gynecologic cancer. PURPOSE: This randomized clinical trial is studying epidural analgesia to see how well it works compared to patient-controlled analgesia in treating patients who have undergone surgery for gynecologic cancer.
Interventions
- DRUG fentanyl citrate
- DRUG hydromorphone hydrochloride
- DRUG ropivacaine hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2005-03 |
| Est. Completion | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00295945
The ClinicalTrials.gov registry entry for NCT00295945 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which fentanyl citrate is the first listed.
NCT00295945 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00295945 about?
NCT00295945 is a clinical study titled "Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer". RATIONALE: Giving pain medication into the space between the wall of the spinal canal and the covering of the spinal cord or giving it into a vein may help lessen pain caused by cancer surgery. It is not yet known whether epidural analgesia is more effective than patient-controlled analgesia in cont...
What is the current status of trial NCT00295945?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2005-03. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00295945?
The interventions under investigation include: fentanyl citrate (DRUG), hydromorphone hydrochloride (DRUG), ropivacaine hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00295945?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.